CVS Health (CVS) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1266501006

(NYSE:CVS Stock) CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island. Web URL: https://www.cvshealth.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for CVS Health (CVS) - Stock Price & Dividends

CVS Stock Overview

Market Cap in USD 97,027m
Sector Healthcare
Industry Healthcare Plans
GiC SubIndustry Health Care Services
TER 0.00%
IPO / Inception 1984-12-17

CVS Stock Ratings

Fundamental 2.93
Dividend 7.11
Growth 5y 3.53
Rel. Performance vs Sector -2.22
Analysts 4.19
Fair Price Total Ret. 73.54
Fair Price DCF 221.99

CVS Dividends

Yield 12m 3.21%
Yield on Cost 5y 4.68%
Dividends CAGR 5y 3.89%
Payout Consistency 96.8%

CVS Growth Ratios

Growth 12m -8.48%
Growth Correlation 12m 7%
Growth Correlation 3m 32%
CAGR 5y 7.81%
CAGR / Mean Drawdown 0.58
Sharpe Ratio 12m -0.54
Alpha vs SP500 12m -30.28
Beta vs SP500 5y weekly 0.77
CAPM 7.37%
Average Daily Range 2m 1.98%
Regime Oscillator 77.13
Volatility GJR Garch 1y 24.69%
Price / SMA 50 1.55%
Price / SMA 200 9.36%
Current Volume 18723.2k
Average Volume 20d 12641.4k

External Links for CVS Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of CVS stocks?
As of February 22, 2024, the stock is trading at USD 77.15 with a total of 18,723,154 shares traded.
Over the past week, the price has changed by +0.97%, over one month by +4.36%, over three months by +14.35% and over the past year by -8.91%.
Why is CVS stock down?
Check with which Index or Commodity CVS has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return CVS Return S&P 500
1 Month 4.36% 2.85%
3 Months 14.35% 10.14%
12 Months -8.91% 26.48%
What is the forecast for CVS stock price target?
According to ValueRays Forecast Model, CVS CVS Health will be worth about 79.4 in February 2025. The stock is currently trading at 77.15. This means that the stock has a potential upside of +2.94%.
Issuer Forecast Upside
Wallstreet Target Price 88.6 14.8%
Analysts Target Price 90.2 16.9%
ValueRay Target Price 79.4 2.9%